OptMed is a privately-held medical device company engaged in the development, manufacturing and commercialization of a line of surgical adhesives based on a unique, proprietary platform polymer chemistry called methylidene malonate.
BondEase™ Topical Skin Adhesive, OptMed’s first clinical indication, received 510(k) marketing clearance from FDA.